This inventor holds 1 USPTO granted patent. Top assignee: Syneurx International (Taiwan) Corp.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Wei-En Hsu: Innovator in Central Nervous System Treatments
Introduction: Wei-En Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of central nervous system disorders. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents: Wei-En Hsu holds a patent for the "Use of lithium benzoate for treating central nervous system disorders." This patent outlines methods for treating central nervous system (CNS) disorders or attenuating pain using a lithium benzoate compound. His work in this area has the potential to improve the quality of life for many individuals suffering from these conditions.
Career Highlights: Hsu's career is marked by his dedication to research and innovation. He is currently associated with Syneurx International (Taiwan) Corp., where he continues to explore new therapeutic avenues. His commitment to advancing medical science is evident in his focused research efforts.
Collaborations: Throughout his career, Wei-En Hsu has collaborated with notable colleagues, including Guochuan Emil Tsai and Hong-Jung Chen. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion: Wei-En Hsu's contributions to the treatment of central nervous system disorders exemplify the impact of innovation in healthcare. His patent and ongoing research efforts highlight the importance of continued exploration in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
